IRIS
CLEMENTI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.969
NA - Nord America 1.396
AS - Asia 1.060
SA - Sud America 9
OC - Oceania 7
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.445
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.382
SE - Svezia 1.057
CN - Cina 558
SG - Singapore 440
IT - Italia 351
RU - Federazione Russa 321
FI - Finlandia 83
DE - Germania 49
IE - Irlanda 49
IN - India 34
CA - Canada 14
GB - Regno Unito 11
NL - Olanda 11
RO - Romania 10
FR - Francia 8
PH - Filippine 6
SA - Arabia Saudita 6
AU - Australia 5
HU - Ungheria 5
BE - Belgio 4
CL - Cile 4
IR - Iran 4
BR - Brasile 3
HK - Hong Kong 3
CZ - Repubblica Ceca 2
JP - Giappone 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
TW - Taiwan 2
AT - Austria 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 4.445
Salva come PNG Salva come JPEG
Città #
Shanghai 384
Princeton 359
Lawrence 356
Singapore 295
Ashburn 166
Milan 158
Moscow 134
New York 101
Helsinki 82
Dublin 46
Boardman 33
Pune 33
Seattle 23
Dallas 22
Washington 21
Bologna 20
Guangzhou 20
Rome 20
Los Angeles 15
Shenzhen 15
Beijing 12
Borås 10
London 8
Jiaxing 7
Toronto 7
Turin 7
Santa Clara 6
St Petersburg 6
Budapest 5
Jeddah 5
Vittoria 5
Ancona 4
Hangzhou 4
Hanover 4
Quanzhou 4
Quezon City 4
Santiago 4
Xi'an 4
Angera 3
Ballincollig 3
Busto Arsizio 3
Frankfurt Am Main 3
Gatchina 3
Jinan 3
Kassel 3
Melbourne 3
Palermo 3
Riccione 3
Rockville 3
Segrate 3
South San Francisco 3
Southend-on-sea 3
São Paulo 3
Varese 3
Albano Laziale 2
Amsterdam 2
Brescia 2
Brussels 2
Cento 2
Changsha 2
Chongqing 2
Clifton 2
Como 2
Foshan 2
Frankfurt am Main 2
Ghent 2
Kunming 2
Las Vegas 2
Littleton 2
Magdeburg 2
Naaldwijk 2
Naples 2
Napoli 2
Omsk 2
Orlando 2
Ottawa 2
Padova 2
Paris 2
Pisa 2
Pomigliano d'Arco 2
Portland 2
Prague 2
Rosarno 2
Shijiazhuang 2
Sydney 2
Taipei 2
Torre Del Greco 2
Vaprio d'Adda 2
Verona 2
Wuxi 2
Almaty 1
Auckland 1
Bacoor 1
Baoding 1
Bari 1
Bloemfontein 1
Buffalo 1
Cagliari 1
Central 1
Cesano Maderno 1
Totale 2.539
Salva come PNG Salva come JPEG
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 52
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 45
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 42
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 34
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 34
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 33
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 33
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 32
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 31
Biobanking for COVID-19 research 31
Laparoscopic right hemicolectomy: the SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective trial on 1225 cases comparing intra corporeal versus extra corporeal ileo-colic side-to-side anastomosis 31
A Biologically-validated HCV E1E2 Heterodimer Structural Model 31
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 30
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 29
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 29
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 29
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 28
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 28
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 27
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 26
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 26
Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo 26
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 25
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 25
2-Aminothiazolones as Anti-HIV Agents That Act as gp120-CD4 Inhibitors 25
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 25
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 25
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 25
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 24
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 24
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 24
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 24
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 24
A SINGLE-STEP DNA EXTRACTION PROCEDURE FOR THE DETECTION OF SERUM HEPATITIS-B VIRUS SEQUENCES BY THE POLYMERASE CHAIN-REACTION 23
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 23
The interferon landscape along the respiratory tract impacts the severity of COVID-19 23
Characterization of GBV-C infection in HIV-1 infected patients 22
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 22
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 22
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 22
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 22
Viral Respiratory Pathogens and Lung Injury 22
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 22
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 21
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 21
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 21
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 21
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 21
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 21
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 20
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 20
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 20
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 20
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 20
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 20
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 20
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 20
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 20
A NOVEL PROCEDURE FOR QUANTITATIVE POLYMERASE CHAIN-REACTION BY COAMPLIFICATION OF COMPETITIVE TEMPLATES 19
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 19
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 19
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 19
Coronaviridae and SARS-associated coronavirus strain HSR1 19
IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation 19
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 19
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 19
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 19
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 19
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 18
A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection 18
Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen 18
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 18
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis 18
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 18
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection 18
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 18
Protocols and self-checking plans for the safety of post-covid-19 balneotherapy 18
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 17
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 17
Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections 17
A closer look at prion strains: Characterization and important implications 17
HCV E2 core structures and mAbs: something is still missing 17
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 17
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial 17
Steps and routes of HCV infection: The great promise of new anti-viral targets 17
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 17
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 17
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 16
GB Virus C and Survival in Persons with HIV Infection 16
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection 16
Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL 16
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir 16
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. 16
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 16
"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3 16
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 16
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 16
Semen infections in men with primary infertility in the real-life setting 16
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 16
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 16
Totale 2.236
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 4 0 0 0 0 3
2020/202177 5 1 1 8 6 15 17 13 1 7 2 1
2021/2022232 6 3 20 72 19 18 15 15 12 18 8 26
2022/20231.989 811 463 167 18 26 224 71 112 71 5 13 8
2023/2024936 21 44 151 95 68 228 22 79 5 41 45 137
2024/20251.313 607 80 49 131 126 320 0 0 0 0 0 0
Totale 4.735